1-Propionyl-LSD, a somewhat new derivative of the copyright drug LSD, is increasingly surfacing in the academic community and gray marketplaces. Primarily synthesized as a theoretical research tool, it’s eliciting interest due to its supposedly different pharmacological profile compared to LSD, though preliminary human studies are currently avail